Pharmacokinetics and pharmacodynamics of sitagliptin, an inhibitor of dipeptidyl peptidase IV, in healthy subjects: results from two randomized, double-blind, placebo-controlled studies with single oral doses. - Herman,GA.; Stevens,C.; Van Dyck,K.; Bergman,A.; Yi,B.; Smet,M De.; Snyder,K.; Hilliard,D.; Tanen,M.; Tanaka,W.; Wang,AQ.; Zeng,W.; et al. (Clin Pharmacol Ther, 2005)